Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy followed by fertility-sparing surgery for stage IB2 cervical cancer
NL-OMON54356Phase 2Recruiting
- Sponsor
- Princess Margaret Cancer Centre
- Start
- Apr 2021
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Cervical Cancer (CC), sponsored by Princess Margaret Cancer Centre. Primary endpoint: Rate of functional uterus. Started Apr 2021; status: recruiting.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NL-OMON54356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54356.